27 - 29 March, 2018
Philadelphia, PA

Media Center

Download 2017 Full Agenda

The 6th Annual Anti-Counterfeiting for Pharmaceuticals Summit takes a comprehensive approach to understand the latest regulations for the DSCSA to remain compliant and uphold quality throughbrand protections plans and anti-counterfeiting strategies. Get your copy of the Full Agenda! Or have it sent to your inbox by emailing Gabbie.Dixon@iqpc.com

Fast Track Your Attendance

Anti-counterfeiting for Pharma Registration Form

We are taking early registrations for this fantastic event. Simply download this form and send it back to enquiryiqpc@iqpc.com to fast track your attendance to this industry-leading event!

Justify Your Trip Letter

Present your manager with this customizable letter detailing the reasons why you should attend the upcoming event and you'll be sure to receive approval.

Attendee Snapshot

Detailed is an abbreviated list of Anti-Counterfeiting executives who attended the last iteration of the event. Will you be there to see what they experienced?

Presentations

TWENTY-FIRST CENTURY THEFT: Brand Protection Strategies in the Digital Age

Christopher Reed, Senior Counsel, Content Protection Policy at Fox Entertainment Group, covers contributing factors to growth of counterfeiting, payment processors as red flags, cooperative approaches to brand protection, and more. 

AmerisourceBergen: DSCSA Serialization and Pilot Programs

Matt Sample, from AmerisourceBergen, describes his experiences using DSCSA Serialization and Pilot Programs inside his organization in regards to traceability.

How Lexmark Curtailed Counterfeiting and Diversion By Creating A More Intelligent Supply Chain

Is your company contemplating the best strategies to reduce the threat of counterfeiting? Learn about how Lexmark halted these threats with serialization, authentication, and a track and trace strategy through its partnership with Verify Brand! 

Cutting-Edge Issues in Brand & Content Protection

Justin Pierce, Partner at Venable, and Cynthia Tregillis, Senior Director, Brand Protection & Trademark Law at Western Digital, go into preventative measures for Border & Customs, the Dark Web, Grey Markets, and more in this presentation.

Infographics

Nipped in the Bud: The Largest Counterfeit Seizures Worldwide

Global counterfeiting is on the rise for a variety of industries, not just pharmaceuticals. This infographic details some of the most high-profile counterfeit goods seizures in recent years, and weighs them against the staggering global scope of the issue - the battles yet to be fought. 

Sponsorship Information

Pharma Anti-Counterfeiting - SPONSORSHIP PROSPECTUS

Please complete the fields below to receive your copy of the 6th Pharma Anti-Counterfeiting & Brand Protection Summit prospectus which includes:

Sponsorship Opportunities | Attendee Profile | Sponsorship Packages

Pharma ACBP - Attendee Snapshot

Please complete the fields below to receive your copy of the 6th Pharma Anti-Counterfeiting & Brand Protection Summit Attendee Snapshot.

Whitepapers

Anti-Counterfeiting in Pharmaceuticals: How Serialization Challenges Play a Part

One of the major aspects of anti-counterfeiting and brand protection for pharmaceuticals is the implementation of serialization along the supply chain. Ahead of the 6th Pharma Anti-Counterfeiting & Brand Protection summit, we examined the role that serialization challenges play on counterfeiting in pharmaceuticals, as well as sessions from the upcoming event that can help to provide more insight. To learn more about these challenges, as well as specifics regarding our corresponding sessions, make sure to download the report.

Interviews with Industry Leaders

Intellectual Property In The Pharmaceutical Industry: Ligia Garta

Legal IQ spoke to Ligia Gata, IP Manager at Bioingenium, to discover the IP challenges faced by the Pharmaceutical industry in 2015. In this interview, Ligia provides insight on the importance of IP for R&D centers and SMEs, the key elements to consider for effectively preserving intellectual property, cutting costs using IP and she responds to the claim 'do patent rights stand in the way of getting treatment to those who need it?' 

Presentations

Fighting Counterfeit Pharmaceuticals in Colombia

Eugene Hackett, Director, Corporate Security, Bristol-Myers Squibb Company, discusses the improvements in the penal law, the private/public partnership and best practices for combating counterfeits with a focus on Columbia in this past presentation.

Leveraging Serialization/E-Pedigree Mandates to Achieve Brand Protection and Operational Efficiency

Steve Stein, Technical Accounts Manager at KODAK and John J. DiPalo, Chief Operating Officer at Acsis, discuss a century of regulatory change from products to packaging to pedigree in this past presentation.

Addressing Complicity to Obtain Fake Pharmaceuticals: A Market Survey of Brazilian, Russian, Indian, Chinese and U.S. Consumers

Dr. Peggy E. Chaudry, of Villanova School of Business at Villanova University, discusses the top five harmful commodities seized, the pharmaceutical crime incidents, illegal internet pharmacies and the proposed new sentencing guidelines to handle them in this past presentation.

Curbing Diversion and Counterfeits from Entering the Supply Chain

Bruce L. Gundy is responsible for directing investigations involving crimes against AmerisourceBergen Corporation. In this past presentation, he discusses curbing diversion and counterfeits entering the supply chain, the five phases of investigation and lessons learned in the investigations.

Podcasts

Pharma Counterfeiting: A $75 Billion Problem

Peggy Chaudhry is one of the leading experts on pharmaceutical anti-counterfeiting and gray markets. An economist, Professor of International Business at Villanova, and author of “Protecting Your Intellectual Property Rights,” Peggy is at the forefront of this costly and dangerous problem.

Whitepapers

Handheld Analyzers for the Rapid and Accurate Screening of Counterfeit Pharmaceuticals

Counterfeit and substandard medicines have serious human health and economic costs the magnitude of the counterfeit and substandard drug problem has gained significant public attention due to a number of high profile incidents and greater media focus. According to the Centers for Disease Control and Prevention (CDC), an estimated 10% – 30% of medicines sold in developing countries are counterfeit.

Portable Spectrometers for Pharmaceutical Counterfeit Detection

Technological advancements in Micro-Electromechanical Systems
(MEMS) for NIR, and in the telecommunication laser industry for Raman, along with advances in optical and detector components miniaturization for both, have led to drastic reductions in size of these spectrometers which have made them portable. This whitepaper is co-authored by speaker Ravi Kalyanaraman of Bristol-Myers Squibb.

Achieving Scannable GS1 Codes for DSCSA Compliance

Counterfeit and diverted pharmaceuticals are major problems that put consumer health and company reputations at risk in the global market. As part of an effort to overhaul track and trace rules and increase the accuracy of supply chain information, the U.S. Food and Drug Administration (FDA) is implementing widespread changes for the pharmaceutical industry.

Screening and Detecting Counterfeit Biologics Drugs

Government health agencies and pharmaceutical manufacturers are finding ways to fight counterfeit and substandard drugs by identifying them from manufacturing, throughout the supply chain, and eventually when they reach the public after they are sold in the retail pharmacies. This whitepaper is co-authored by speaker Ravi Kalyanaraman of Bristol-Myers Squibb.

Near-Infrared Spectral Signature Development and Validation for Counterfeit Drug Detection Using Portable Spectrometer

Near-Infrared (NIR) and Raman spectral techniques, which are complimentary in nature, have been used widely to detect counterfeit drugs. Both techniques are rapid, onintrusive and nondestructive that can be used for the analysis of many classes of pharmaceutical dosage forms.This whitepaper is co-authored by speaker Ravi Kalyanaraman of Bristol-Myers Squibb.

Portable Raman Spectroscopy for Pharmaceutical Counterfeit Detection

One of the effective ways to authenticate a pharmaceutical product is by using Raman spectroscopy to obtain a unique spectral ‘fingerprint’ of the authentic drug product itself that can be used to evaluate a suspect sample by spectral comparison to determine if it is indeed a counterfeit. This whitepaper is co-authored by speaker Ravi Kalyanaraman of Bristol-Myers Squibb.

Interviews

Counterfeit or Not? Use a Spectrometer to Find Out

What’s the most invaluable tool you’ll need to detect counterfeit pharmaceuticals at a crime scene? Spectrometers, of course.

Analytical technologies – especially portable spectrometers – play a large role in detecting counterfeit products. One of the top spectrometer experts is Ravi Kalyanaraman, an Associate Director at Bristol Myers Squibb.

Highlighting the Role of Carrier Management in Supply Chain Security

Jason Blumenauer is the Director of Global Security at Cardinal Health and an expert in supply chain security. In this interview, he discusses the role of carrier management; how he sources and selects the right carriers, assessing opportunities for theft, tips for proactively protecting against theft and, finally, appropriately responding to thefts when they occur.

Illegal Online Pharmacies: A Potentially Fatal Threat

Marjorie Clifton is executive director of the Center for Safe Internet Pharmacies and has over 16 years of communications, advocacy and public policy experience. She regularly appears on CNN, CNBC, Fox, and national radio.